Genetic Technologies Limi... (GENE)
NASDAQ: GENE
· Real-Time Price · USD
0.77
0.01 (0.65%)
At close: Nov 14, 2024, 10:00 PM
Genetic Ratios and Metrics
Financials in AUD. Fiscal
year is
July - June.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
PE Ratio | -0.47 | n/a | -0.02 | n/a | -0.03 | n/a | -0.03 | n/a | -0.07 | -20.75 | -0.09 | -28.12 | -0.19 | -37.65 | -0.15 | n/a |
PEG Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | 0.21 | -0.00 | 0.28 | -0.00 | 0.38 | n/a | n/a |
PS Ratio | 2.19 | n/a | 0.12 | n/a | 0.15 | n/a | 0.18 | n/a | 0.18 | 46.80 | 0.64 | 126.37 | 26.95 | 411.59 | 129.26 | n/a |
PB Ratio | 5.74 | n/a | 0.10 | n/a | 0.06 | n/a | 0.07 | n/a | 0.05 | 27.34 | 0.07 | 26.68 | 0.13 | 25.84 | 0.12 | n/a |
P/FCF Ratio | -1.85 | n/a | -0.12 | n/a | -0.37 | n/a | -0.27 | n/a | -0.55 | n/a | -0.32 | -109.15K | -1.06 | -244.42 | -0.55 | n/a |
P/OCF Ratio | -1.86 | n/a | -0.12 | n/a | -0.37 | n/a | -0.27 | n/a | -0.57 | n/a | -0.32 | n/a | -1.09 | -250.28 | -0.57 | n/a |
OCF/S Ratio | -1.18 | n/a | -0.98 | n/a | -0.4 | n/a | -0.66 | n/a | -0.32 | n/a | -2.01 | n/a | -24.76 | -1.64 | -227.07 | n/a |
Debt / Equity Ratio | 0.48 | n/a | 0.08 | n/a | 0.05 | n/a | 0.06 | n/a | 0.04 | n/a | 0.01 | n/a | 0.01 | n/a | 0.02 | n/a |
Quick Ratio | 0.83 | n/a | 1.55 | n/a | 3.07 | n/a | 1.98 | n/a | 3.76 | 3.76 | 5.96 | 5.96 | 15.77 | 15.77 | 14.48 | n/a |
Current Ratio | 0.88 | n/a | 1.67 | n/a | 3.17 | n/a | 2.08 | n/a | 3.86 | 3.86 | 6.08 | 6.08 | 15.82 | 15.82 | 14.57 | n/a |
Asset Turnover | 0.78 | n/a | 0.47 | n/a | 0.31 | n/a | 0.26 | n/a | 0.23 | 0.14 | 0.09 | 0.08 | 0.00 | 0.03 | 0.00 | n/a |
Interest Coverage | -89.5 | n/a | -401.72 | n/a | -335.9 | n/a | -339.68 | n/a | n/a | n/a | -311.01 | n/a | -631.28 | n/a | -598.83 | n/a |
Return on Equity | -3.06 | n/a | -1.33 | n/a | -0.56 | n/a | -0.5 | n/a | -0.2 | -0.33 | -0.2 | -0.24 | -0.17 | -0.17 | -0.2 | n/a |
Return on Assets | -0.9 | n/a | -0.76 | n/a | -0.42 | n/a | -0.35 | n/a | -0.16 | -0.08 | -0.17 | -0.09 | -0.16 | -0.08 | -0.18 | n/a |
Return on Invested Capital | -1.22 | n/a | -0.97 | n/a | -0.39 | n/a | -0.45 | n/a | -0.18 | -0.11 | -0.19 | -0.1 | -0.17 | -0.09 | -0.22 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.58 | n/a | -0.5 | n/a | -0.27 | n/a | -0.37 | n/a | 0.62 | 0.67 | 0.36 | 0.67 | -3.54 | 0.99 | -16.44 | n/a |
Net Profit Margin | -1.17 | n/a | -1.62 | n/a | -1.39 | n/a | -1.31 | n/a | -0.69 | -0.56 | -1.89 | -1.12 | -34.6 | -2.73 | -211.43 | n/a |
Pretax Profit Margin | -1.17 | n/a | -1.62 | n/a | -1.39 | n/a | -1.35 | n/a | -0.94 | -0.57 | -2.48 | -1.12 | -39 | -2.73 | -244.29 | n/a |
Operating Profit Margin | -0.72 | n/a | -1.3 | n/a | -1.01 | n/a | -1.3 | n/a | -0.91 | -0.63 | -2.42 | -1.13 | -40.17 | -2.83 | -270.45 | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -1.14 | n/a | -1.55 | n/a | -1.31 | n/a | -1.22 | n/a | -0.87 | -0.62 | -2.37 | -1.05 | -35.7 | -2.71 | -235.25 | n/a |